International
Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial
Injection · 10 mg · vial
Dragon Pharma Thymosin Alpha-1 is a synthetic 28 amino acid copy of the natural immune peptide, supplied as a 10 mg lyophilized research vial. It is studied as a biological response modifier in T-cell maturation and cytokine signalling. Clinical work uses a twice-weekly schedule.
GMP-manufactured and HPLC-verified, with a Certificate of Analysis on file per batch. Thymosin Alpha-1 10 mg for sale with U.S. domestic and international shipping.
Product overview
Dragon Pharma Thymosin Alpha-1 10 mg Research Vial
Dragon Pharma Thymosin Alpha-1 is a 10 mg lyophilized vial of the synthetic 28 amino acid peptide, also written as thymalfasin and sold elsewhere as Zadaxin. It is a biological response modifier rather than a hormone: the research focus is the T-cell side of immunity and the cytokine signals around it, which places the compound in the immune and longevity group of the line.
- 10 mg lyophilized powder in a single vial - research use
- Synthetic 28 amino acid immune peptide (thymalfasin)
- GMP-manufactured and HPLC-verified - COA on file per batch
- U.S. and international shipping
How Thymosin Alpha-1 Works
The peptide is a synthetic copy of a natural thymic signal studied as an immune modulator: animal work in thymus-free animals showed restored immune function, and the clinical literature covers chronic viral hepatitis, sepsis and immune support during cancer treatment. Pharmacokinetics are predictable: a peak 1 to 2 hours after a 900 mcg subcutaneous dose and a half-life of 2 to 3 hours, which is why clinical schedules inject twice weekly rather than daily. A 2023 review of hospitalised COVID-19 patients found no reduction in mortality or hospital stay, so the compound should not be read as a broad antiviral. The thymus-centred side of the shelf is covered by the Generic Peptides Thymosin Alpha-1 page.
Reconstitution & Storage
Dissolve the lyophilizate with bacteriostatic water against the vial wall, without shaking. A 10 mg vial in 5 ml gives 2 mg/ml, so 0.1 ml equals 200 mcg or 10 units on a U-100 syringe. Clinical reference doses are 0.8 to 6.4 mg twice weekly, and the standard hepatitis B schedule uses 1.6 mg twice weekly for about 12 weeks, six injections from this vial. Those figures are medical cross-checks, not a protocol for the research vial. Store the powder at 2-8 C away from light and use a solution within about 28 to 30 days. Bacteriostatic water is the standard diluent here.
Quality & Authenticity
Each batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis kept per batch. Store the vial upright, protect it from light and avoid repeated freeze-thaw cycles. The bioregulators on the same shelf, such as Livagen, follow the same GMP and COA convention.
For laboratory research only. Consult a healthcare professional before use.
Specifications
| Trade Name | Thymosin Alpha-1 |
| Generic Name | Thymalfasin (28 amino acid peptide) |
| Manufacturer | Dragon Pharma |
| Dosage | 10 mg per vial |
| Package | 1 lyophilized vial |
| Drug Class | Research peptide, immune modulator |
| Half-Life | 2-3 hours after subcutaneous dosing |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | U.S. domestic and international |
Stacks
Research compounds only. Consult a healthcare professional before any use. Amounts shown are clinical or vendor reference figures, not a dosing instruction.
FAQ
Before you ask
Questions, answered
It is a synthetic 28 amino acid copy of a natural thymic peptide, also called thymalfasin, and it is studied as a biological response modifier. Research directions include T-cell maturation and function, cytokine signalling, chronic viral hepatitis, sepsis and immune support during cancer treatment. Those are research directions, not promised outcomes, and there is no approved U.S. form of the peptide.
Add bacteriostatic water against the wall of the vial and swirl, do not shake. A 10 mg vial with 5 ml of diluent gives 2 mg/ml, where 0.1 ml is 200 mcg or 10 units on a U-100 syringe; the same ratio comes from 2 mg in 1 ml, so any vial size follows one simple rule. Keep the solution at 2-8 C and use it within about 28 to 30 days without freezing.
Clinical references sit at 0.8 to 6.4 mg subcutaneously twice weekly, and the standard hepatitis B schedule uses 1.6 mg twice weekly for about 12 weeks. The twice-weekly rhythm comes from the short half-life of 2 to 3 hours: the peptide clears quickly and the schedule keeps a background level rather than a single long action. From a 10 mg vial, 1.6 mg per injection works out to six injections, roughly three weeks of that schedule.
The fact sheet describes no liver toxicity signal and no fluid retention for the peptide, and injection site redness and irritation are the usual local complaint with this class. Rare allergic reactions are possible, which is why a small test amount is the sensible first step with any new peptide. The larger caveat is that a 2023 review in hospitalised COVID-19 patients found no benefit on mortality or length of stay, so expectations should stay modest.
The peptide is not named in the WADA prohibited list in the fact sheet, which means the sources checked show no ban rather than a documented permission. That distinction matters for anyone subject to testing: absence from the list is not a green light, and the status should be checked against the current list before any decision.
Store the lyophilized vial at 2-8 C, protected from light, and keep it dry; the vendor convention for long-term storage of the powder is a freezer. Do not refreeze a solution that has already been thawed. GenXXLGear ships Thymosin Alpha-1 10 mg with U.S. domestic and international shipping, and every batch carries a Certificate of Analysis from third-party HPLC testing.
Be the first to share your experience with Dragon Pharma Thymosin Alpha-1 10 mg Immune Peptide Vial
Log in to write a reviewComplete the cycle
Stack it with
International
International
Available Domestic
U.S Domestic
Available Domestic